Apeloa Pharmaceutical Hits Day High with Strong 3.12% Intraday Surge

Apeloa Pharmaceutical Co., Ltd. has experienced a notable uptick in its stock performance, gaining 3.12% on March 11, 2026. The stock reached an intraday high of CNY 18.83, reflecting a significant moment in its trading activity. Over the past week, Apeloa has shown a robust performance with an 8.55% increase, outperforming the China Shanghai Composite, which rose by only 1.25% during the same period. Despite this positive short-term trend, the company's longer-term performance metrics indicate challenges. Over the past year, Apeloa's stock has returned 4.29%, significantly lagging behind the China Shanghai Composite's 22.49% return. Additionally, the company has reported a decline in net sales of 14.55% and has faced negative results for the last two consecutive quarters. With a market capitalization of CNY 21,412 million, Apeloa operates within the pharmaceuticals and biotechnology sector. The company maintains a P/E ratio of 20.00 and a dividend yield of 3.88%. However, its return on equity stands at 13.29%, and it has recorded a decrease in operating cash flow, indicating areas for potential improvement.